XII MEDICAL RAISES $45 MILLION IN SERIES B FINANCING TO ADVANCE BEST-IN-CLASS NEUROMODULATION THERAPY FOR OBSTRUCTIVE SLEEP APNEA

Omega Funds and Intuitive Ventures join top-tier syndicate of healthcare investors to support ongoing clinical activities UNION CITY, Calif., Aug. 21, 2024 /PRNewswire/ — XII Medical, Inc., a clinical-stage medical technology company developing innovative therapies for obstructive sleep…